Assoc. Prof. Dr. Şefika Nur Aksoy

Formation et spécialisation

• İstanbul Kız Lisesi
• Cerrahpaşa Tıp Fakültesi — Études de médecine

Expérience professionnelle

• Suluova SSK Hastanesi — Service obligatoire
• Cibali SSK Dispanseri
• Haseki Eğitim ve Araştırma Hastanesi — Biochimie médicale
• 75. Yıl Kadın Doğum Hastanesi, Gaziantep
• Gaziantep Üniversitesi Sağlık Hizmetleri Meslek Yüksekokulu
• 2006–2011 Faculté de médecine de l’Université de Gaziantep, biochimie et biochimie clinique — Professeure adjointe
• 2011–2016 Faculté de médecine de l’Université de Gaziantep, biochimie et biochimie clinique — Maître de conférences
• 2008–2016 Hôpital de la faculté de médecine de l’Université de Gaziantep — Enseignante responsable du laboratoire
• 01.06.2016 Memorial Diyarbakır Hastanesi
• 2019–2020 Kolan International Hospital, İstanbul
• Liv Hospital Gaziantep

Domaines d’expertise

• Biochimie médicale et laboratoire clinique

Adhésions professionnelles

• Société turque de biochimie
• Association turque de biochimie clinique

Prix

• 2004 AACC Annual Meeting, Los Angeles — Prix de recherche
• 2009 35e Congrès national d’hématologie — Prix de l’industrie pour l’étude du polymorphisme G-463A de la myéloperoxydase et des taux enzymatiques dans la leucémie lymphoïde chronique et le myélome multiple
• 2009 5e Congrès national de médecine d’urgence — Prix d’honneur Dr. John Fowler, premier prix de communication orale

Publications scientifiques

• Aksoy ŞN, Savaş E, Sucu M, Kisacik B, Kul S, Zengin O. Association between red blood cell distribution width and disease activity in patients with Behçet's disease. J Int Med Res. 2015 Dec;43(6):765-73
• Akcali A, Zengin F, Aksoy SN, Zengin O. Fatigue in Multiple Sclerosis: Is it related to cytokines and hypothalamic-pituitary-adrenal axis? Mult Scler Relat Disord. 2017 Jul;15:37-41.
• Tabur S, Aksoy ŞN, Korkmaz H, Ozkaya M, Aksoy N, Akarsu E. Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma. Tumour Biol. 2015 Apr;36(4):2667-74.
• Dai AI, Aksoy SN, Demiryürek AT. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity. J Child Neurol. 2016 Feb;31(2):184-9
• Tabur S, Korkmaz H, Ozkaya M, Aksoy SN, Akarsu E. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy? Diabetol Metab Syndr. 2015 Apr 24;7:36
• Dai AI, Demiryürek S, Aksoy SN, Perk P, Saygili O, Güngör K. Maternal Iron Deficiency Anemia as a Risk Factor for the Development of Retinopathy of Prematurity. Pediatr Neurol. 2015 Aug;53(2):146-50.
• Korkmaz H, Tabur S, Savaş E, Özkaya M, Aksoy ŞN, Aksoy N, Akarsu E. Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases. Balkan Med J. 2016 Sep;33(5):547-551.
• Çetkin M , Demirel C, Kızılkan N, Aksoy N, Erbağcı H. Evaluation of the mobile phone electromagnetic radiation on serum iron parameters in rats. Afr Health Sci. 2017 Mar; 17(1): 186–190.
• Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis. Savas E, Aksoy N, Pehlivan Y, Sayiner ZA, Oztürk ZA, Tabur S, Orkmez M, Onat AM. Wien Klin Wochenschr. 2014 Jun;126(11-12):341-6.
• Aksoy SN , Saygılı EI , Bulbul F , Bahar A , Savas H, Vırıt O , Altındag A , Bayram A and Tarakçıoğlu M. Myeloperoxidase enzyme levels and oxidative stress in bipolar disorders. Afr. J. Biotechnol 9 (22), 3318-3323, May 2010
• Saygili E.I, Aksoy SN, Gurler B, A. Aksoy, O. Erel & M. Ozaslan Oxidant/Antioxidant Status of Patients with Diabetic and Senile Cataract. Biotechnol. & Biotechnol. Eq., 24(1), 1648-1652, 2010
• Aksoy SN, Erbagci Z, Saygili EI, Sever T, Erbagci AB, Pehlivan S. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo. Eur J Dermatol. Nov-Dec 2009;19(6):576-80
• Aksoy N, Aksoy M, Cakmak M, Gergerlioglu HS, Davutoglu V, Soydinc S, Meram I “ Increased homocysteine in heart failure: a result of renal impairment? “,Clin chem Lab Med .44(11):1324-1329 (2006)
• Aksoy N, Aksoy M, Bagci C, Gergerlioğlu HS, Çelik H, Herken E, Yaman A, Tarakçıoğlu M,Soydinç S, Sari I, Davutoğlu. ‘’Pistachio intake increases high density lipoprotein levels and inhibits low density lipoprotein oxidation in rats’’,Tohoku J Exp Med.212(1):43-8 (2007)
• Aksoy N, Ozer O, Sari I, Sucu M, Aksoy M, Geyikli I. ‘’Contribution of Renal Function Impairment to Unexplained Troponin T Elevations in Congestive Heart Failure. Renal Failure, 31(4):272–277 (2009)
• Saygili EI, Aksoy N, Pehlivan M, Sever T, Yilmaz M, Cimenci IG, Pehlivan S. Enzyme levels and G-463A polymorphism of myeloperoxidase in chronic lymphocytic leukemia and multiple myeloma. Leuk Lymphoma. 2009 Oct 9.
• Dinçkal MH, Aksoy SN, Aksoy M,Davutoğlu,Dinçkal N, Akdemir I,”QT dispersion in the risk stratification of patients with unstable angina : correlation with clinical course ,troponin T and scintigraphy.” Acta Cardiol.59(3):283-9 (2004)
• Dinçkal MH, Aksoy N, Aksoy M, Davutoğlu V,Soydinç S,Kirilmaz A,Dinçkal N,Akdemir I “Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia.”Acta Cardiol.58(5):389-96(2003)
• Akdemir I, Aksoy N, Aksoy M, Davutoğlu V, Dinçkal H,” Does exercise induced severe ischemia result in elevation of plasma troponin-T level in patients with chronic coronary disease,”Acta Cardiol.,57(1):13-8 (2002)
• Dinçkal MH, Aksoy N, Aksoy M, Davutoğlu, Dinçkal N, Soydinç S, Akdemir I,”Acute rest perfusion imaging in high risk unstable angina :association with troponin T and clinical endpoints”,Int J Cardiovasc Imaging,19(6):511-7 (2003)
• Sari I, Baltaci Y, Bagci C, Davutoglu V, Erel O, Celik H, Ozer O, Aksoy N, Aksoy M. Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: A prospective study. Nutrition. 2009; 1–6
• Ozer O, Davutoglu V, Ercan S, Akcay M, Sari I, Sucu M, Celik A, Aksoy N, Cicek H, Al B.Plasma urotensin II as a marker for severity of rheumatic valve disease.Tohoku J Exp Med. 2009 May;218(1):57-62
• Erbağcı AB, Deveci R, Akarsu E, Tiryaki Ö, Aksoy ŞN. Effect of intensive insulin therapy on systemic nitric oxide levels and adenosine deaminase activity in secondary sulfonylurea failure. Biochemia Medica 2009;19(2):166–76